RecruitingEarly Phase 1

Pencil Beam Scanning in Patients With Renal Tumors

United States28 participantsStarted 2017-12-26

Plain-language summary

This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.

Who can participate

Age range0 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Any patient with favorable histology (FH), stage III disease
✓. Any patient with focal or diffuse anaplasia
✓. Any patient with CCSK

What they're measuring

Occurrence of any non-hematologic toxicity that occurs within 90 days following the start of proton therapy assessed with with NCI Common toxicity criteria (CTC Version 4.0) grades].

Timeframe: 90 days

Trial details

NCT IDNCT03810651

SponsorChildren's Hospital of Philadelphia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-30

Contact for this trial

Christine Hill-Kayser, MD

215-590-2810 hill@uphs.upenn.edu

View on ClinicalTrials.gov More Renal Tumor trials